Eads & Heald Wealth Management’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $754K | Buy |
7,275
+2,192
| +43% | +$249K | 0.38% | 93 |
|
|
2025
Q4 | $513K | Sell |
5,083
-2,274
| -31% | -$247K | 0.25% | 112 |
|
|
2025
Q3 | $907K | Buy |
7,357
+112
| +2% | +$13.9K | 0.43% | 87 |
|
|
2025
Q2 | $870K | Sell |
7,245
-824
| -10% | -$110K | 0.43% | 90 |
|
|
2025
Q1 | $1.19M | Sell |
8,069
-60
| -0.7% | -$9.16K | 0.6% | 70 |
|
|
2024
Q4 | $1.32M | Buy |
8,129
+180
| +2% | +$29.4K | 0.65% | 69 |
|
|
2024
Q3 | $1.29M | Buy |
7,949
+622
| +8% | +$92.2K | 0.61% | 76 |
|
|
2024
Q2 | $1M | Sell |
7,327
-447
| -6% | -$62.1K | 0.48% | 84 |
|
|
2024
Q1 | $1.19M | Buy |
7,774
+507
| +7% | +$75.7K | 0.55% | 83 |
|
|
2023
Q4 | $1.04M | Buy |
7,267
+545
| +8% | +$72.7K | 0.5% | 85 |
|
|
2023
Q3 | $881K | Sell |
6,722
-375
| -5% | -$57K | 0.46% | 88 |
|
|
2023
Q2 | $1.13M | Sell |
7,097
-235
| -3% | -$37.9K | 0.56% | 82 |
|
|
2023
Q1 | $1.16M | Sell |
7,332
-85
| -1% | -$12.7K | 0.57% | 79 |
|
|
2022
Q4 | $1.04M | Buy |
7,417
+287
| +4% | +$40.7K | 0.53% | 80 |
|
|
2022
Q3 | $915K | Sell |
7,130
-1,573
| -18% | -$227K | 0.52% | 83 |
|
|
2022
Q2 | $1.23M | Sell |
8,703
-23
| -0.3% | -$3.29K | 0.66% | 68 |
|
|
2022
Q1 | $1.21M | Buy |
8,726
+1,444
| +20% | +$221K | 0.56% | 81 |
|
|
2021
Q4 | $1.27M | Sell |
7,282
-214
| -3% | -$35.7K | 0.55% | 84 |
|
|
2021
Q3 | $1.24M | Sell |
7,496
-535
| -7% | -$92.1K | 0.6% | 83 |
|
|
2021
Q2 | $1.45M | Buy |
8,031
+830
| +12% | +$151K | 0.71% | 71 |
|
|
2021
Q1 | $1.39M | Sell |
7,201
-10
| -0.1% | -$1.93K | 0.71% | 71 |
|
|
2020
Q4 | $1.46M | Buy |
7,211
+755
| +12% | +$156K | 0.78% | 62 |
|
|
2020
Q3 | $1.36M | Sell |
6,456
-179
| -3% | -$39.9K | 0.81% | 59 |
|
|
2020
Q2 | $1.46M | Buy |
6,635
+60
| +0.9% | +$12K | 0.88% | 55 |
|
|
2020
Q1 | $1.14M | Sell |
6,575
-57
| -0.9% | -$9.42K | 0.81% | 60 |
|
|
2019
Q4 | $1.02M | Sell |
6,632
-90
| -1% | -$13.5K | 0.54% | 79 |
|
|
2019
Q3 | $1.02M | Buy |
6,722
+40
| +0.6% | +$6.32K | 0.57% | 75 |
|
|
2019
Q2 | $1.02M | Buy |
6,682
+519
| +8% | +$79.3K | 0.58% | 77 |
|
|
2019
Q1 | $989K | Buy |
6,163
+200
| +3% | +$31K | 0.57% | 76 |
|
|
2018
Q4 | $919K | Buy |
5,963
+84
| +1% | +$13.1K | 0.61% | 70 |
|
|
2018
Q3 | $884K | Sell |
5,879
-2,067
| -26% | -$294K | 0.51% | 81 |
|
|
2018
Q2 | $1.07M | Sell |
7,946
-1,926
| -20% | -$238K | 0.66% | 72 |
|
|
2018
Q1 | $1.31M | Sell |
9,872
-812
| -8% | -$109K | 0.83% | 58 |
|
|
2017
Q4 | $1.59M | Sell |
10,684
-8
| -0.1% | -$1.09K | 0.94% | 48 |
|
|
2017
Q3 | $1.41M | Buy |
10,692
+135
| +1% | +$18.1K | 0.88% | 54 |
|
|
2017
Q2 | $1.41M | Sell |
10,557
-338
| -3% | -$45.6K | 0.9% | 51 |
|
|
2017
Q1 | $1.47M | Buy |
10,895
+191
| +2% | +$24.7K | 0.95% | 52 |
|
|
2016
Q4 | $1.28M | Buy |
10,704
+207
| +2% | +$24.4K | 0.88% | 58 |
|
|
2016
Q3 | $1.31M | Sell |
10,497
-49
| -0.5% | -$6.42K | 0.91% | 54 |
|
|
2016
Q2 | $1.46M | Sell |
10,546
-424
| -4% | -$55K | 1% | 46 |
|
|
2016
Q1 | $1.38M | Buy |
10,970
+1,105
| +11% | +$140K | 0.96% | 49 |
|
|
2015
Q4 | $1.25M | Sell |
9,865
-729
| -7% | -$90.5K | 0.87% | 59 |
|
|
2015
Q3 | $1.22M | Sell |
10,594
-1,030
| -9% | -$116K | 0.87% | 54 |
|
|
2015
Q2 | $1.21M | Sell |
11,624
-259
| -2% | -$27.9K | 0.8% | 61 |
|
|
2015
Q1 | $1.31M | Sell |
11,883
-435
| -4% | -$47.2K | 0.84% | 58 |
|
|
2014
Q4 | $1.28M | Sell |
12,318
-468
| -4% | -$46.8K | 0.82% | 60 |
|
|
2014
Q3 | $1.23M | Sell |
12,786
-774
| -6% | -$70K | 0.83% | 60 |
|
|
2014
Q2 | $1.24M | Sell |
13,560
-73
| -0.5% | -$6.54K | 0.82% | 62 |
|
|
2014
Q1 | $1.2M | Sell |
13,633
-1,020
| -7% | -$89.5K | 0.79% | 60 |
|
|
2013
Q4 | $1.36M | Sell |
14,653
-820
| -5% | -$73.9K | 0.9% | 56 |
|
|
2013
Q3 | $1.26M | Sell |
15,473
-525
| -3% | -$44.3K | 0.9% | 56 |
|
|
2013
Q2 | $1.33M | Buy |
+15,998
| New | +$1.38M | 0.94% | 56 |
|
Other funds holding CLX
VCM
VPM
DAM
Eads & Heald Wealth Management's CLX Position: Q1 2026 in Review
Eads & Heald Wealth Management increased its Clorox (CLX) stake by 43% in Q1 2026, buying an estimated $249K and bringing the position to 7,275 shares worth $754K. The position accounts for 0.38% of the portfolio, ranked #93.
Eads & Heald Wealth Management first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.59M in Q4 2017. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- Eads & Heald Wealth Management held 7,275 shares of Clorox worth $754K as of Q1 2026.
- Eads & Heald Wealth Management bought 2,192 Clorox shares in Q1 2026, an estimated $249K.
- Clorox made up 0.38% of Eads & Heald Wealth Management's portfolio in Q1 2026, its #93 holding.
- Eads & Heald Wealth Management first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
- Eads & Heald Wealth Management's Clorox position peaked at $1.59M in Q4 2017.
- 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.